Parathyroid Scintigraphy in Patients with Primary Hyperparathyroidism: ^99mTc Sestamibi SPECT and SPECT/CT

References

• 1 KearnsAE, Thompson GB. Medical and surgical management of hyperparathyroidism. Mayo Clin Proc2002; 77(1): 87–91. [Published correction appears in Mayo Clin Proc 2002;77(3):298.]
  Medline Google Scholar
• 2 TaniegraED. Hyperparathyroidism. Am Fam Physician2004; 69(2): 333–339.
  Medline Google Scholar
• 3 RudaJM, Hollenbeak C, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg2005; 132(3): 359–372.
  Medline Google Scholar
• 4 RussellCF, Laird JD, Ferguson WR. Scan-directed unilateral cervical exploration for parathyroid adenoma: a legitimate approach? World J Surg1990; 14(3): 406–409.
  Medline Google Scholar
• 5 SuliburkJW, Perrier ND. Primary hyperparathyroidism. Oncologist2007; 12(6): 644–653.
  Medline Google Scholar
• 6 HarnsbergerHR, Osborn AG, Ross J, Macdonald A. Thyroid gland and parathyroid glands. In: Diagnostic and surgical imaging anatomy: brain, head and neck, spine. Salt Lake City, Utah: Amirsys, 2006.
  Google Scholar
• 7 DufourDR, Wilkerson SY. Factors related to parathyroid weight in normal persons. Arch Pathol Lab Med1983; 107(4): 167–172.
  Medline Google Scholar
• 8 PellitteriPK, Sofferman RA, Randolph GW. Surgical management of parathyroid disorders. In: Cummings CW, Haughey BH, Thomas JR, Harker LA, Flint PW, eds. Cummings otolaryngology: head and neck surgery. 4th ed. Philadelphia, Pa: Mosby, 2005.
  Google Scholar
• 9 PhitayakornR, McHenry CR. Incidence and location of ectopic abnormal parathyroid glands. Am J Surg2006; 191(3): 418–423.
  Medline Google Scholar
• 10 DeLellisRA. Surgical pathology of the parathyroid glands. In: Randolph G, ed. Surgery of the thyroid and parathyroid glands. St. Louis, Mo: Elsevier, 2003;571–577.
  Google Scholar
• 11 BilezikianJP, Silverberg SJ. Clinical practice. Asymptomatic primary hyperparathyroidism. N Engl J Med2004; 350(17): 1746–1751.
  Medline Google Scholar
• 12 BilezikianJP, Potts JT Jr, Fuleihan Gel-H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab2002; 87(12): 5353–5361.
  Medline Google Scholar
• 13 RubelloD, Giannini S, De Carlo E, et al. Minimally invasive (99m)Tc-sestamibi radioguided surgery of parathyroid adenomas. Panminerva Med2005; 47(2): 99–107.
  Medline Google Scholar
• 14 LavelyWC, Goetze S, Friedman KP, et al. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase 99mTc-sestamibi parathyroid scintigraphy. J Nucl Med2007; 48(7): 1084–1089.
  Medline Google Scholar
• 15 RodgersSE, Hunter GJ, Hamberg LM, et al. Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery2006; 140(6): 932–940.
  Medline Google Scholar
• 16 LumachiF, Zucchetta P, Marzola MC, et al. Advantages of combined technetium-99m-sestamibi scintigraphy and high-resolution ultrasonography in parathyroid localization: comparative study in 91 patients with primary hyperparathyroidism. Eur J Endocrinol2000; 143(6): 755–760.
  Medline Google Scholar
• 17 SolorzanoCC, Carneiro-Pla DM, Irvin GL 3rd. Surgeon-performed ultrasonography as the initial and only localizing study in sporadic and primary hyperparathyroidism. J Am Coll Surg2006; 202(1): 18–24.
  Medline Google Scholar
• 18 AhujaAT, Wonga KT, Ching AS, et al. Imaging for primary hyperparathyroidism—what beginners should know. Clin Radiol2004; 59(11): 967–976.
  Medline Google Scholar
• 19 JohnsonNA, Tublin ME, Ogilvie JB. Parathyroid imaging: technique and role in the preoperative evaluation of primary hyperparathyroidism. AJR Am J Roentgenol2007; 188(6): 1706–1715.
  Medline Google Scholar
• 20 FerlinG, Borsato N, Camerani M, Conte N, Zotti D. New perspectives in localizing enlarged parathyroids by technetium-thallium subtraction scan. J Nucl Med1983; 24(5): 438–441.
  Medline Google Scholar
• 21 CoakleyAJ, Kettle AG, Wells CP, O’Doherty MJ, Collins RE. 99mTc-sestamibi—a new agent for parathyroid imaging. Nucl Med Commun1989; 10(11): 791–794.
  Medline Google Scholar
• 22 BergenfelzA, Tennvall J, Valdermarsson S, Lindblom P, Tibblin S. Sestamibi versus thallium subtraction scintigraphy in parathyroid localization: a prospective comparative study in patients with predominantly mild primary hyperparathyroidism. Surgery1997; 121(6): 601–605.
  Medline Google Scholar
• 23 CasasAT, Burke GJ, Sathyanarayana, Mansberger AR Jr, Wei JP. Prospective comparison of technetium-99m-sestamibi/iodine-123 radionuclide scan versus high-resolution ultrasonography for the preoperative localization of abnormal parathyroid glands in patients with previously unoperated primary hyperparathyroidism. Am J Surg1993; 166(4): 369–373.
  Medline Google Scholar
• 24 WeberCJ, Vansant J, Alazraki N. Value of technetium-99m-sestamibi iodine-123 imaging in reoperative parathyroid surgery. Surgery1993; 114(6): 1011–1018.
  Medline Google Scholar
• 25 TailleferR, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med1992; 33(10): 1801–1807.
  Medline Google Scholar
• 26 ArbabAS, Koizumi K, Toyama K, Araki T. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. J Nucl Med1996; 37(9): 1551–1556.
  Medline Google Scholar
• 27 PalestroCJ, Tomas MB, Tronco GG. Radionuclide imaging of the parathyroid glands. Semin Nucl Med2005; 35(4): 266–276.
  Medline Google Scholar
• 28 SandrockD, Merino MJ, Norton JA, Neumann RD. Parathyroid imaging by Tc/Tl scintigraphy. Eur J Nucl Med1990; 16(8–10): 607–613.
  Medline Google Scholar
• 29 LiehnJC, Delisle MJ, Flament JB. Improvement of parathyroid Tl-Tc scintigraphy by using a new image subtraction method. Eur J Nucl Med1988; 14(4): 184–189.
  Medline Google Scholar
• 30 RauthJD, Sessions RB, Shupe SC, Ziessman HA. Comparison of Tc-99m MIBI and Tl-201/Tc-99m pertechnetate for diagnosis of primary hyperparathyroidism. Clin Nucl Med1996; 21(8): 602–608.
  Medline Google Scholar
• 31 ChenCC, Holder LE, Scovill WA, Tehan AM, Gann DS. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT. J Nucl Med1997; 38(6): 834–839.
  Medline Google Scholar
• 32 NeumannDR, Esselstyn CB Jr, Go RT, Wong CO, Rice TW, Obuchowski NA. Comparison of double-phase 99mTc-sestamibi with 123I-99mTc-sesta-mibi subtraction SPECT in hyperparathyroidism. AJR Am J Roentgenol1997; 169(6): 1671–1674.
  Medline Google Scholar
• 33 LeslieWD, Dupont JO, Bybel B, Riese KT. Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout. Eur J Nucl Med Mol Imaging2002; 29(12): 1566–1570.
  Medline Google Scholar
• 34 KrauszY, Horne T, Wynchank S, Halevy A. Lateral neck imaging for spatial localization of parathyroid tissue. Nucl Med Biol1995; 22(3): 391–394.
  Medline Google Scholar
• 35 ArveschougAK, Bertelsen H, Vammen B, Brochner-Mortensen J. Preoperative dual-phase parathyroid imaging with tc-99m-sestamibi: accuracy and reproducibility of the pinhole collimator with and without oblique images. Clin Nucl Med2007; 32(1): 9–12.
  Medline Google Scholar
• 36 MokaD, Voth E, Dietlein M, Larena-Avellaneda A, Schicha H. Technetium 99m-MIBI-SPECT: a highly sensitive diagnostic tool for localization of parathyroid adenomas. Surgery2000; 128(1): 29–35.
  Medline Google Scholar
• 37 SchachterPP, Issa N, Shimonov M, Czerniak A, Lorberboym M. Early, postinjection MIBI-SPECT as the only preoperative localizing study for minimally invasive parathyroidectomy. Arch Surg2004; 139(4): 433–437.
  Medline Google Scholar
• 38 SlaterA, Gleeson FV. Increased sensitivity and confidence of SPECT over planar imaging in dual-phase sestamibi for parathyroid adenoma detection. Clin Nucl Med2005; 30(1): 1–3.
  Medline Google Scholar
• 39 LorberboymM, Minski I, Macadziob S, Nikolov G, Schachter P. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma. J Nucl Med2003; 44(6): 904–908.
  Medline Google Scholar
• 40 ProfanterC, Wetscher GJ, Gabriel M, et al. CT-MIBI image fusion: a new preoperative localization technique for primary, recurrent, and persistent hyperparathyroidism. Surgery2004; 135(2): 157–162.
  Medline Google Scholar
• 41 GayedIW, Kim EE, Broussard WF, et al. The value of 99m-Tc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas and hyperplasia. J Nucl Med2005; 46(2): 248–252.
  Medline Google Scholar
• 42 KrauszY, Bettman L, Guralnik L, et al. Technetium-99m-MIBI SPECT/CT in primary hyperparathyroidism. World J Surg2006; 30(1): 76–83.
  Medline Google Scholar
• 43 KaczirekK, Prager G, Kienast O, et al. Combined transmission and (99m)Tc-sestamibi emission tomography for localization of mediastinal parathyroid glands. Nuklearmedizin2003; 42(5): 220–223.
  Medline Google Scholar
• 44 RufJ, Seehofer D, Denecke T, et al. Impact of image fusion and attenuation correction by SPECT-CT on the scintigraphic detection of parathyroid adenomas. Nuklearmedizin2007; 46(1): 15–21.
  Medline Google Scholar
• 45 ChenCC, Skarulis MC, Fraker DL, Alexander R, Marx SJ, Spiegel AM. Technetium-99m-sestamibi imaging before reoperation for primary hyperparathyroidism. J Nucl Med1995; 36(12): 2186–2191.
  Medline Google Scholar
• 46 BajoghliM, Muthukrishnan A, Mountz J. Posterior bulge sign for parathyroid adenoma on Tc-99m MIBI SPECT. Clin Nucl Med2006; 31(8): 470–471.
  Medline Google Scholar
• 47 YusimA, Aspelund G, Ahrens W, et al. Intrathyroidal parathyroid adenoma. Thyroid2006; 16(6): 619–620.
  Medline Google Scholar
• 48 BenardF, Lefebvre B, Beuvon F, Langlois MF, Bisson G. Rapid washout of technetium-99m-MIBI from a large parathyroid adenoma. J Nucl Med1995; 36(2): 241–243.
  Medline Google Scholar
• 49 SfakianakisGN, Irvin GL 3rd, Foss J, et al. Efficient parathyroidectomy guided by SPECT-MIBI and hormonal measurements. J Nucl Med1996; 37(5): 798–804.
  Medline Google Scholar
• 50 ChanTY, Serpell JW, Chan O, Gaunt JI, Young AE, Nunan TO. Misinterpretation of the upper parathyroid adenoma on thallium-201/technetium-99m subtraction scintigraphy. Br J Radiol1991; 64(757): 1–4.
  Google Scholar
• 51 KimSC, Kim S, Inabet W, Krynyckyi B, Machec J, Kim CK. Appearance of descended superior parathyroid adenoma on SPECT parathyroid imaging. Clin Nucl Med2007; 32(2): 90–93.
  Medline Google Scholar
• 52 TaiebD, Hassad R, Sebag F, et al. Tomoscintigraphy improves the determination of the embryologic origin of parathyroid adenomas, especially in apparently inferior glands: imaging features and surgical implications. J Nucl Med Technol2007; 35(3): 135–139.
  Medline Google Scholar
• 53 ClarkPB, Case D, Watson NE Jr, Perrier ND, Morton KA. Enhanced scintigraphic protocol required for optimal preoperative localization before targeted minimally invasive parathyroidectomy. Clin Nucl Med2003; 28(12): 955–960.
  Medline Google Scholar
• 54 ChiuB, Sturgeon C, Angelos P. What is the link between nonlocalizing sestamibi scans, multigland disease, and persistent hypercalcemia? A study of 401 consecutive patients undergoing parathyroidectomy. Surgery2006; 140(3): 418–422.
  Medline Google Scholar
• 55 LumachiF, Marzola MC, Zucchetta P, Tregnaghi A, Cecchin D, Bui F. Hyperfunctioning parathyroid tumours in patients with thyroid nodules: sensitivity and positive predictive value of high-resolution ultrasonography and 99mTc-sestamibi scintigraphy. Endocr Relat Cancer2003; 10(3): 419–423.
  Medline Google Scholar
• 56 ErbilY, Barbaros U, Yanik BT, et al. Impact of gland morphology and concomitant thyroid nodules on preoperative localization of parathyroid adenomas. Laryngoscope2006; 116(4): 580–585.
  Medline Google Scholar
• 57 TailleferR, Robidoux A, Lambert R, Turpin S, Laperriere J. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med1995; 36(10): 1758–1765.
  Medline Google Scholar
• 58 YenTC, Tzen KY, Lee CM, Tsai CC. Squamous cell carcinoma of the lung mimicking an ectopic mediastinal parathyroid adenoma demonstrated by Tc-99m sestamibi in a hypercalcemic patient. Clin Nucl Med1999; 24(11): 895–896.
  Medline Google Scholar
• 59 YaparZ, Kibar M, Sukan A, Paydas S, Zeren H, Inal M. Coincidental visualization of an atypical bronchial carcinoid on Tc-99m-sestamibi scan in Kallmann’s syndrome. Ann Nucl Med2002; 16(1): 61–65.
  Medline Google Scholar
• 60 GlaserC, Pruckmayer M, Staudenherz A, Rasse M, Lang S, Leitha T. Utility of technetium-99m-sestamibi to assess osseous tumour spread. J Nucl Med1996; 37(9): 1526–1528.
  Medline Google Scholar
• 61 KossWG, Brown MR, Balfour JF. A false-positive localization of a parathyroid adenoma with technetium Tc 99m sestamibi scan secondary to a thyroid follicular carcinoma. Arch Surg1996; 131(2): 216–217.
  Medline Google Scholar
• 62 ScottAM, Kostakoglu L, O’Brien JP, Straus DJ, Abdel-Dayem HM, Larson SM. Comparison of technetium-99m-MIBI and thallium-201-chloride uptake in primary thyroid lymphoma. J Nucl Med1992; 33(7): 1396–1398.
  Medline Google Scholar
• 63 ShanmugamN, Johns W, Chasse K, Gupta SM. Serendipitous detection of metastatic thyroid cancer during I-123 Tc-99m sestamibi dual parathyroid imaging. Clin Nucl Med2005; 30(8): 550–551.
  Medline Google Scholar
• 64 LeslieWD, Riese KT, Mohamed C. Sestamibi retention in reactive lymph node hyperplasia: a cause of false-positive parathyroid localization. Clin Nucl Med2000; 25(3): 216–217.
  Medline Google Scholar
• 65 MudunA, Kocak M, Unal S, Cantez S. Tc99m MIBI accumulation in remnant thymus: a cause of false-positive interpretation in parathyroid imaging. Clin Nucl Med1995; 20(4): 379–380.
  Medline Google Scholar
• 66 BhattacharyaA, Mittal BR, Bhansali A, Radotra BD, Behera A. Cervical paraganglioma mimicking a parathyroid adenoma on Tc-99m sestamibi scintigraphy. Clin Nucl Med2006; 31(4): 234–236.
  Medline Google Scholar
• 67 CampeauRJ, Reuther WL, Wayne J. False-positive Tc99m sestamibi examination for parathyroid adenoma in a case of asymmetrical salivary gland enlargement. Clin Nucl Med1999; 24(9): 723–724.
  Medline Google Scholar
• 68 BhatnagarA, Vezza PR, Bryan JA, Atkins FB, Ziessman HA. Technetium-99m-sestamibi parathyroid scintigraphy: effect of P-glycoprotein, histology and tumor size on detectability. J Nucl Med1998; 39(9): 1617–1620.
  Medline Google Scholar
• 69 TorregrosaJV, Fernandez-Cruz L, Canalejo A, et al. 99mTc-sestamibi scintigraphy and cell cycle in parathyroid glands of secondary hyperparathyroidism. World J Surg2000; 24(11): 1386–1390.
  Medline Google Scholar
• 70 SunSS, Shiau YC, Lin CC, Kao A, Lee CC. Correlation between P-glycoprotein (P-gp) expression in parathyroid and Tc-99m MIBI parathyroid image findings. Nucl Med Biol2001; 28(8): 929–933.
  Medline Google Scholar
• 71 PonsF, Torregrosa JV, Fuster D. Biological factors influencing parathyroid localization. Nucl Med Commun2003; 24(2): 121–124.
  Medline Google Scholar
• 72 PineroA, Rodriguez JM, Martinez-Barba E, Canteras M, Stiges-Serra A, Parrilla P. Tc99m-sesta-mibi scintigraphy and cell proliferation in primary hyperparathyroidism: a causal or casual relationship? Surgery2003; 134(1): 41–44.
  Medline Google Scholar
• 73 TurgutB, Elagoz S, Erselcan T, et al. Preoperative localization of parathyroid adenomas with technetium-99m methoxyisobutylisonitrile imaging: relationship with P-glycoprotein expression, oxyphilic cell content, and tumoral tissue volume. Cancer Biother Radiopharm2006; 21(6): 579–590.
  Medline Google Scholar